TrialNeurology2017
A phase 3 trial of IV immunoglobulin for Alzheimer disease.
Norman R Relkin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
75 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialNeurology2017
Norman R Relkin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.